HeartFocus (V.1.1.1) vs InVision Precision Cardiac Amyloid
AI Verdict
Choose HeartFocus (V.1.1.1) if…
Choose HeartFocus if your primary goal is to empower a broader range of healthcare professionals, including those with less ultrasound experience, to acquire diagnostic-quality cardiac ultrasound images. This tool is ideal for point-of-care settings, training programs, or situations where real-time guidance for probe positioning and automatic clip acquisition are critical for consistent image quality across various device types.
View HeartFocus (V.1.1.1) →Choose InVision Precision Cardiac Amyloid if…
Choose InVision Precision Cardiac Amyloid if your focus is on enhancing the diagnostic accuracy and early detection of cardiac amyloidosis within an established echocardiography workflow. This AI-powered software is specifically designed to analyze existing echocardiogram studies for this often-missed condition, providing clinicians with precise insights to improve outcomes for patients with heart failure symptoms.
View InVision Precision Cardiac Amyloid →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFocus (V.1.1.1) | InVision Precision Cardiac Amyloid |
|---|---|---|
| Pricing | Contact for pricing | Subscription |
| Deployment | App or SDK, integrated with compatible ultrasound devices (e.g., Butterfly Network's handheld ultrasound devices). | Software as a Medical Device (SaMD), integrated into clinical workflows for echocardiography labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HeartFocus (V.1.1.1)Tool A, HeartFocus, explicitly focuses on empowering novice users to perform diagnostic-quality heart ultrasounds through real-time AI guidance for probe positioning. This direct support for less experienced users and the availability of a certification program indicate a strong emphasis on ease of use and accessibility for a broader range of healthcare professionals.
Clinical Value
InVision Precision Cardiac AmyloidTool B, InVision Precision Cardiac Amyloid, offers a highly specific and impactful clinical value by aiding in the earlier detection and reduction of misdiagnosis for cardiac amyloidosis, a life-threatening and often underdiagnosed disease. Its AI algorithm is evidence-based and has been peer-reviewed and published in JAMA Cardiology, providing strong validation for its clinical utility.
Pricing & Value
InVision Precision Cardiac AmyloidTool B, InVision Precision Cardiac Amyloid, provides greater transparency regarding its pricing, stating a starting subscription cost of $49/month and inviting contact for enterprise and volume discounts. In contrast, Tool A, HeartFocus, only states 'contact for pricing,' offering less upfront information about its cost structure.
Enterprise Readiness
InVision Precision Cardiac AmyloidTool B, InVision Precision Cardiac Amyloid, explicitly states it is HIPAA compliant and offers enterprise pricing and volume discounts, demonstrating a clear focus on scalability and readiness for larger organizational deployments. While Tool A is FDA-cleared and likely compliant, it does not explicitly state HIPAA compliance or offer specific enterprise pricing details in the provided information.
Innovation
HeartFocus (V.1.1.1)Tool A, HeartFocus, demonstrates significant innovation by providing real-time AI guidance for ultrasound probe positioning, enabling novice users to perform diagnostic-quality heart ultrasounds. This capability has the potential to democratize access to cardiac imaging and fundamentally change how and where these procedures are performed, aligning with its tagline 'A new standard for cardiac imaging u2014 anywhere'.
Support & Docs
HeartFocus (V.1.1.1)Tool A, HeartFocus, explicitly offers a 'POCUS HeartFocus Certification program' and serves as a 'Training resource for medical teachers and ultrasound competencies.' These dedicated programs and resources indicate a robust system for user support, training, and comprehensive documentation, which goes beyond the clinical validation mentioned for Tool B.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFocus (V.1.1.1) | InVision Precision Cardiac Amyloid |
|---|---|---|
| Name | HeartFocus (V.1.1.1) | InVision Precision Cardiac Amyloid |
| Company | Deski | InVision Medical Technology Corporation |
| Primary Clinical Focus | Enables healthcare professionals, including novices, to perform diagnostic-quality heart ultrasounds with real-time AI guidance. | AI-powered software for echocardiography to detect cardiac amyloidosis, aiming for earlier detection and improved patient outcomes. |
| Key Capability | AI-enabled real-time guidance for ultrasound probe positioning; Automatic detection and recording of diagnostic-quality clips. | AI-powered detection of cardiac amyloidosis; Evaluation of transthoracic echocardiogram studies. |
| Supported Echocardiographic Views/Studies | Supports acquisition of 10 standard echocardiographic views | Evaluation of transthoracic echocardiogram studies (apical-4-chamber and parasternal-long-axis view videos) |
| Target User/Skill Level | Empowers novice users to perform diagnostic-quality heart ultrasounds | Aids clinicians in diagnosing and assessing patients with heart failure symptoms |
Videos
Demos, reviews, and walkthroughs featuring HeartFocus (V.1.1.1) and InVision Precision Cardiac Amyloid.
Frequently Asked Questions
More Comparisons
More matchups featuring HeartFocus (V.1.1.1) or InVision Precision Cardiac Amyloid
- InVision Precision Cardiac Amyloid vs EchoNext
- HeartFocus (V.1.1.1) vs EchoNext
- HeartFocus (V.1.1.1) vs SCENARIA View Phase
- InVision Precision Cardiac Amyloid vs MAGNETOM Cima.X
- InVision Precision Cardiac Amyloid vs V7 Diagnostic Ultrasound System
- HeartFocus (V.1.1.1) vs V7 Diagnostic Ultrasound System